Drospirenone and Ethinyl Estradiol Tablets
Designed to support pregnancy prevention, formulated to target hormonal cycles and to support reproductive health management.
Strengths: 3/0.03mg
Where to Check Availability
Medicine details
- Conditions
- Alternative names
Yasmin; Yaz
- Therapeutic class
Combined oral contraceptive
- Pharmacological class
Progestogen and oestrogen
- Known off-label uses
acne; premenstrual dysphoric disorder
- Contraindications
history of blood clots; uncontrolled hypertension; breast cancer
- Precautions and warnings
increased risk of venous thromboembolism; monitor blood pressure; stop smoking
- Minor side effects
nausea; headache; breast tenderness
- Moderate side effects
weight fluctuation; mood swings; unscheduled bleeding
- Dosage forms
Film-coated tablet
- Administration route
Oral use
- Prescription status
POM
- Manufacturer
Bayer
- Onset Time
7–14 days
- Duration
24 hours
- Storage instructions
Store below 25°C.
- Drug interactions
st. john's wort; carbamazepine; rifampicin
- Age restrictions
Suitable for women of reproductive age.
Serious side effects
venous thromboembolism — requires immediate medical attention; stroke — requires immediate medical attention
Patient summary
Designed to support pregnancy prevention, formulated to target hormonal cycles and to support reproductive health management.
Mechanism of action
The combination acts primarly by suppressing ovulation through feedback inhibition of gonadotropins, while also altering cervical mucus and the endometrium to prevent fertilisation.
Pregnancy and breastfeeding
Pregnancy: Contraindicated; stop immediately if pregnancy occurs. Breastfeeding: May reduce milk volume.
Drospirenone and Ethinyl Estradiol Tablets
Designed to support pregnancy prevention, formulated to target hormonal cycles and to support reproductive health management.
Editorial Notes
- Active ingredient(s): Drospirenone, Ethinyl Estradiol
- Listed indication(s): Contraception
Available option
- 63 tablets - 3/0.03 mg1220-3-0-03-mg-14510